ArticleProceedings (Baylor University. Medical Center)2025
Treatment charges for acute coronary syndrome: A retrospective analysis.
Article in Proceedings (Baylor University. Medical Center), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study analyzes the costs associated with treatment strategies for acute coronary syndrome: coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI), and medical management (MM). Methods: This is a substudy of a previous analysis showing improved outcomes with CABG compared to PCI and MM, now focusing on variation in charges based on the type of treatment, hospital length of stay (LOS), and the occurrence of hospital readmission. We extracted total reimbursements, LOS, and readmissions for acute coronary syndrome patients (4267) between 2018 and 2022 from the electronic health record. Results: Expenses related to total charges were higher for CABG patients than PCI patients (+$106,047); however, average daily charges were lower for CABG patients compared to PCI patients (+$14,957). LOS was a primary driver for total charges, as CABG patients stayed 8.35 ± 0.50 days longer than PCI patients on average. The average difference between the total charge amount for readmitted and nonreadmitted patients was $22,765 ± $11,820. Even though readmission increases total charges, the charge per day was still less in patients with readmission due to their longer LOS. Conclusion: The higher total charge amount and lower charge per day in CABG patients compared to PCI patients, as well as readmitted patients, highlights the importance of employing strategies to reduce LOS and minimize charges for CABG and readmissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.